Результати пошуку - Deepa Nanayakkara
- Показ 1 - 3 результатів із 3
-
1
-
2
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial за авторством Flavia Chiuppesi, John A. Zaia, Paul Frankel, Rodica Stan, Jennifer Drake, Brenda Williams, Anne Marie Acosta, Karyn Francis, Randy Taplitz, Janet K Dickter, Sanjeet Dadwal, Alfredo Puing, Deepa Nanayakkara, Patricia Ash, Yujie Cui, Heidi Contreras, Corinna La Rosa, Katrin Tiemann, Yoonsuh Park, Joybelle Medina, Angelina Iniguez, Qiao Zhou, Veronica Karpinski, Daisy Johnson, Katelyn Faircloth, Teadora Kaltcheva, Jenny Nguyen, Mindy Kha, Vu H. Nguyen, Sandra Ortega Francisco, Alba Grifoni, Angela Wong, Alessandro Sette, Felix Wussow, Don J. Diamond
Опубліковано 2022Artigo -
3
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study за авторством Stephen P. Bergin, Roy F. Chemaly, Sanjeet Dadwal, Joshua A. Hill, Yeon Joo Lee, Ghady Haidar, Alfred Luk, Alexander Drelick, Peter Chin‐Hong, Esther Benamu, Fareed Khawaja, Deepa Nanayakkara, Genovefa A. Papanicolaou, Catherine B. Small, Monica Fung, Michelle Barron, Thomas Davis, Micah T. McClain, Eileen K Maziarz, Deng B. Madut, Armando Bedoya, Daniel L Gilstrap, Jamie L. Todd, Christina E. Barkauskas, Robert Bigelow, Jeffrey D. Leimberger, Ephraim L. Tsalik, Olivia Wolf, Mona Mughar, Desiree Hollemon, Radha Duttagupta, Daniel S. Lupu, Sivan Bercovici, Bradley A. Perkins, Timothy A. Blauwkamp, Vance G. Fowler, Thomas L Holland
Опубліковано 2023Artigo
Інструменти для пошуку:
Пов'язані теми
Medicine
Biology
Gene
Internal medicine
Virology
Adverse effect
Alternative medicine
Antibody
Biochemistry
Cohort
Confidence interval
Environmental health
Escherichia coli
Etiology
Genetics
Immunogenicity
Immunology
Klebsiella infections
Klebsiella pneumoniae
Microbiology
Pathology
Placebo
Plasmid
Pneumonia
Population
Prospective cohort study
Recombinant DNA
Seroconversion
Tolerability
Vaccinia